<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04668742</url>
  </required_header>
  <id_info>
    <org_study_id>656677758319</org_study_id>
    <nct_id>NCT04668742</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of the DYNAtraq Device to Prevent Complications in Tracheostomy in Mechanically Ventilated Patients</brief_title>
  <acronym>DYNAtraq</acronym>
  <official_title>A Clinical, Controlled, Randomized Trial to Evaluate the Efficacy and Safety of the New Dynatraq Invention Device to Prevent Complications Associated With Tracheostomy Tubes in Mechanically Ventilated Patients: &quot; Dynatraq-2 Study &quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Cardiovascular de Colombia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Plasticos de Santander Ltda PLADESAN</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundación Cardiovascular de Colombia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although tracheostomy is a common technique in Intensive Care Units (ICU), its complications&#xD;
      can be frequent (between 5% to 40%). Inadequate fixation could favor decannulation, as well&#xD;
      as incorrect alignment of the tracheostomy with respect to the tracheal axis could favor the&#xD;
      appearance of tissue alterations such as ulcers, bleeding or fistulas, as well as obstruction&#xD;
      of the ventilatory obstruction. Having a device that is effective in fixation and alignment&#xD;
      could help in reducing tracheostomy complications, so this study aims to evaluate the effect&#xD;
      and safety of a fixation device for tracheostomy through a randomized clinical trial.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction: Tracheostomy is one of the most frequently required surgical techniques for the&#xD;
      management of hospitalized patients in Intensive Care Units (ICU). This procedure is&#xD;
      justified to facilitate the improvement of the patient, facilitate early rehabilitation,&#xD;
      reduce sedation and analgesia requirements, and reduce the length of stay in the ICU and the&#xD;
      days of mechanical ventilation (MV). However, tracheostomy is associated with various&#xD;
      complications, from mispositioning and accidental decannulation, to hemoptysis, tracheal&#xD;
      fistulas, air leaks, and ventilatory difficulties. In a pre-post quasi-experimental study&#xD;
      where the effect of the DYNAtraq technological innovation device on tracheostomy fixation and&#xD;
      alignment was evaluated, it was found that it can correct 83% of cases, which contrasts with&#xD;
      only 2% when they did not have the device. (p &lt;0.01). This previous study allowed us to&#xD;
      conclude that technological innovation through DYNAtraq is pertinent, relevant and effective&#xD;
      to correct the position of tracheostomy tubes in patients hospitalized in the ICU and under&#xD;
      mechanical ventilation.&#xD;
&#xD;
      Objective: To evaluate the efficacy and safety of the DYNAtraq medical device to keep&#xD;
      tracheostomy tubes in correct alignment and fixation in adult patients with tracheostomy&#xD;
      hospitalized in the ICU and under invasive mechanical ventilation.&#xD;
&#xD;
      Methodology: Randomized, controlled clinical trial (two-parallel arm), assigned in a 1: 1&#xD;
      ratio, in a sample of 74 patients mechanically ventilated in intensive care unit (37 in&#xD;
      intervention group and 37 patients in control group). This study is conducted in two centers&#xD;
      for intensive care patients in two Colombian cities and&#xD;
&#xD;
      The patients randomized to the intervention group will have the external fixation system for&#xD;
      the tracheostomy installed, which is a non-invasive plastic device, from the start of the&#xD;
      tracheostomy to ventilatory weaning. Patients in the control group will receive the usual&#xD;
      management of the tracheostomy given in ICU. To evaluate alignment , the cephalo-caudal (C-C)&#xD;
      and lateral-lateral (L-L) angles will be evaluated through photographs and analyzed with the&#xD;
      MY MEASURES application. The mean values of the angles were obtained in degrees and their 95%&#xD;
      confidence intervals. Angular means were compared using the paired Student's t test.&#xD;
&#xD;
      Expected Results: The DYNAtraq device is expected to be effective in improving the proper&#xD;
      fixation, orientation, and alignment of the tracheostomy tube in mechanically ventilated&#xD;
      patients, reducing the complications of lacerations, bleeding, decannulation, and respiratory&#xD;
      infectious complications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 25, 2019</start_date>
  <completion_date type="Anticipated">November 25, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 25, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>masking of the intervention and control groups in the statistical analysis of the data, which will be represented as group 0 and 1, without identifying whether they are control or intervention</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of mis-alignment of tracheostomy tube</measure>
    <time_frame>72 hours after tracheostomy installation</time_frame>
    <description>Deviation from 95° angle of tracheostomy tube (cephalo-caudal (C-C) and lateral-lateral (L-L) angles) No evidence of alignment of tube though bronchoscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence of complications of tracheostomy</measure>
    <time_frame>72 hours after tracheostomy installation</time_frame>
    <description>Evidence of any complication due to tracheostomy (infections, bleeding, extubation, death)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Presence of skin lesion</measure>
    <time_frame>72 hours after tracheostomy installation</time_frame>
    <description>Safety of the device in skin (adhesive)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Tracheostomy</condition>
  <condition>Mechanical Ventilation Complication</condition>
  <arm_group>
    <arm_group_label>Arm 1: DYNAtraq - tracheostomy fixation device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of DYNatraq installed in chest with skin adhesive and fixed to tracheostomy tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2: Usual management of tracheostomy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No interventions will be used additional to usual management</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DYNAtraq</intervention_name>
    <description>Tracheostomy alignment with DYNAtraq</description>
    <arm_group_label>Arm 1: DYNAtraq - tracheostomy fixation device</arm_group_label>
    <other_name>tracheostomy fixation device</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age&#xD;
&#xD;
          -  Indication for a tracheostomy&#xD;
&#xD;
          -  Signature of informed consent&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Mediastinitis&#xD;
&#xD;
          -  Open chest&#xD;
&#xD;
          -  Chest skin infection /burns anterior region of the thorax&#xD;
&#xD;
          -  Patients requiring reanimation&#xD;
&#xD;
          -  Active phase of COVID-19&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mauricio Orozco-Levi, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundacion Cardiovascular de Colombia- Hospital internacional de Colombia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mauricio Orozco-Levi, Ph.D.</last_name>
    <phone>+576394040</phone>
    <phone_ext>1*056</phone_ext>
    <email>mauricioorozco@fcv.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Diana Carolina Tiga-Loza, Ph.D.</last_name>
    <phone>+576394040</phone>
    <phone_ext>1*056</phone_ext>
    <email>caritotiga@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Internacional de Colombia</name>
      <address>
        <city>Piedecuesta</city>
        <state>Santander</state>
        <zip>683071</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alba Sarmiento, Ph.D</last_name>
      <phone>+576345745</phone>
      <email>albaramirez@fcv.org</email>
    </contact>
    <contact_backup>
      <last_name>Camilo Pizarro</last_name>
      <phone>+57 7 6399292</phone>
      <phone_ext>344</phone_ext>
      <email>camilopizarro@fcv.org</email>
    </contact_backup>
    <investigator>
      <last_name>Mauricio Orozco-Levi, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Diana Rey, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 23, 2020</study_first_submitted>
  <study_first_submitted_qc>December 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 16, 2020</study_first_posted>
  <last_update_submitted>December 11, 2020</last_update_submitted>
  <last_update_submitted_qc>December 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tracheostomy</keyword>
  <keyword>airway</keyword>
  <keyword>complications</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

